Determinants of COVID-19 disease severity in patients with underlying rheumatic disease

CS Santos, CM Morales, ED Álvarez, CÁ Castro… - Clinical …, 2020 - Springer
COVID-19 were admitted to our hospital, of whom 38 (10%) had a rheumatic or musculoskeletal
disease… Patients who died from COVID-19 were older (median age 78.4 IQR 74.5–83.5) …

Course of post COVID-19 disease symptoms over time in the ComPaRe long COVID prospective e-cohort

VT Tran, R Porcher, I Pane, P Ravaud - Nature communications, 2022 - nature.com
… In conclusion, our study shows that most patients with post COVID-19 disease have
symptoms evolving in different patterns but persisting through 1 year. Recovery from the acute …

COVID-19 disease and ophthalmology: an update

MA Amesty, JL Alio del Barrio, JL Alió - Ophthalmology and Therapy, 2020 - Springer
coronavirus disease (COVID-19) caused by the coronavirus … the evidence currently available
on COVID-19 and its ocular … in patients with severe COVID-19 pneumonia and that it is …

The role of miRNAs in COVID-19 disease

M Fani, M Zandi, S Ebrahimi, S Soltani, S Abbasi - Future Virology, 2021 - Taylor & Francis
… Due to the importance of miRNAs in infectious diseases and the concerns about the
increase in the mortality rate caused by COVID-19 disease, especially in immunosuppressed …

[HTML][HTML] Role of hematological parameters in the stratification of COVID-19 disease severity

S Taj, SA Fatima, S Imran, A Lone, Q Ahmed - Annals of medicine and …, 2021 - Elsevier
… to investigate the association of hematological parameters with COVID-19 disease, and to
evaluate the role of hematological parameters in stratification of COVID-19 disease severity. …

[HTML][HTML] Current treatment in COVID-19 disease: a rapid review

M Rodriguez-Guerra, P Jadhav, TJ Vittorio - Drugs in context, 2021 - ncbi.nlm.nih.gov
… evaluated for their efficacy in the management of COVID-19 infection. As noted in a recent
… In a trial headed by the Mayo Clinic for COVID-19 disease, CP was used in approximately …

Collider bias undermines our understanding of COVID-19 disease risk and severity

GJ Griffith, TT Morris, MJ Tudball, A Herbert… - Nature …, 2020 - nature.com
… factor for death (mediated by COVID-19 infection). However, if … to have COVID-19 (ie we
condition on the COVID-19 infection … for disease onset that appears to be protective for disease

Androgen sensitivity gateway to COVID19 disease severity

CG Wambier, A Goren, S Vaño‐Galván… - Drug development …, 2020 - Wiley Online Library
… as a prophylactic treatment could reduce COVID-19 disease burden. Given that certain
anti-androgens such as finasteride carry a low risk of serious adverse events, healthcare workers…

Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, China: a multicentre, retrospective, cohort study

J Tian, X Yuan, J Xiao, Q Zhong, C Yang, B Liu… - The Lancet …, 2020 - thelancet.com
… determine risk factors of COVID-19 disease severity for patients with cancer and COVID-19. …
COVID-19 disease severity was defined on admission on the basis of the WHO guidelines. …

[PDF][PDF] Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected: interim guidance, 13 March 2020

(‎ 2020 World Health Organization - 2020 - apps.who.int
… 2019 冠状病毒病(COVID-19)是由一种新发冠状病毒引起的呼吸道感染,该病毒于 2019 年 12
月在中国武汉市被首 次发现.基因测序的结果显示该病毒属于 β 型冠状病毒,与严重急性呼吸综合…